» Articles » PMID: 25408360

Performance of Time-dependent Propensity Scores: a Pharmacoepidemiology Case Study

Overview
Publisher Wiley
Date 2014 Nov 20
PMID 25408360
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pharmacoepidemiologic studies of acute effects of episodic exposures often must control for many time-dependent confounders. Marginal structural models permit this and provide unbiased estimates when confounders are on the causal pathway. However, if causal pathway confounding is minimal, analyses with time-dependent propensity scores, calculated for time periods defined by individual drug prescriptions, may have better efficiency. We justify time-dependent propensity scores and compare the performance of these methods in a case study from a previous investigation of the risk of medication toxicity death in current users of propoxyphene and hydrocodone, with both substantial time-dependent confounding and a large number of covariates.

Methods: The cohort included Tennessee Medicaid enrollees who filled a qualifying study opioid prescription between 1992 and 2007. We identified 22 time-dependent covariates that accounted for most of the confounding in the original study. We compared analyses with all covariates in the regression model with those based on time-dependent propensity scores and those from marginal structural models.

Results: We identified 489,008 persons with 1,771,295 propoxyphene and 4,088,754 hydrocodone prescriptions. The unadjusted hazard ratio (propoxyphene : hydrocodone) was 0.70 (95%CI, 0.46-1.07). Estimates from inclusion of all covariates in the model, time-dependent propensity score analysis with inverse probability of treatment weighting, and marginal structural models were 1.63 (1.04-2.57), 1.65 (1.01-2.72), and 1.64 (0.83-3.27), respectively. Findings varied little with use of alternative propensity score methods, time origin, or techniques for marginal structural model estimation.

Conclusions: Time-dependent propensity scores may be useful for pharmacoepidemiologic studies with time-varying exposures when causal pathway confounding is limited.

Citing Articles

Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non-Cancer Pain.

Corriere M, Daniel L, Dickson A, Nepal P, Hall K, Plummer W Clin Pharmacol Ther. 2023; 114(5):1050-1057.

PMID: 37548889 PMC: 10592148. DOI: 10.1002/cpt.3019.


Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study.

Waddingham E, Miller A, Dobson R, Matthews P Front Neurol. 2022; 13:799531.

PMID: 35418938 PMC: 8996123. DOI: 10.3389/fneur.2022.799531.


Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study.

Ray W, Chung C, Murray K, Malow B, Daugherty J, Stein C PLoS Med. 2021; 18(7):e1003709.

PMID: 34264928 PMC: 8321368. DOI: 10.1371/journal.pmed.1003709.


Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity.

Kubiszewski P, Sugita L, Kourkoulis C, DiPucchio Z, Schwab K, Anderson C JAMA Neurol. 2020; .

PMID: 32865558 PMC: 7489430. DOI: 10.1001/jamaneurol.2020.3142.


Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.

Magagnoli J, Narendran S, Pereira F, Cummings T, Hardin J, Sutton S Med. 2020; 1(1):114-127.e3.

PMID: 32838355 PMC: 7274588. DOI: 10.1016/j.medj.2020.06.001.


References
1.
Hawton K, Simkin S, Deeks J . Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. BMJ. 2003; 326(7397):1006-8. PMC: 154756. DOI: 10.1136/bmj.326.7397.1006. View

2.
Thapa P, Gideon P, Fought R, Ray W . Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol. 1995; 142(2):202-11. DOI: 10.1093/oxfordjournals.aje.a117619. View

3.
Westreich D, Cole S, Tien P, Chmiel J, Kingsley L, Funk M . Time scale and adjusted survival curves for marginal structural cox models. Am J Epidemiol. 2010; 171(6):691-700. PMC: 2877453. DOI: 10.1093/aje/kwp418. View

4.
Ali M, Groenwold R, Pestman W, Belitser S, Hoes A, de Boer A . Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease. Eur J Epidemiol. 2013; 28(4):291-9. DOI: 10.1007/s10654-013-9766-2. View

5.
Holford T . The analysis of rates and of survivorship using log-linear models. Biometrics. 1980; 36(2):299-305. View